ResearchPad - e-letters:-comments-and-responses https://www.researchpad.co Default RSS Feed en-us © 2020 Newgen KnowledgeWorks <![CDATA[Comment on Davis et al. Development and Validation of a Simple Hip Fracture Risk Prediction Tool for Type 2 Diabetes: The Fremantle Diabetes Study Phase I. Diabetes Care 2018;42:102–109]]> https://www.researchpad.co/article/elastic_article_14396 <![CDATA[Response to Comment on Lacy et al. Long-term Glycemic Control and Dementia Risk in Type 1 Diabetes. Diabetes Care 2018;41:2339–2345]]> https://www.researchpad.co/article/Nbd3b154c-d7b3-47bc-90d2-f8dd17f9520e ]]> <![CDATA[Comment on Desai et al. Health Care Utilization and Burden of Diabetic Ketoacidosis in the U.S. Over the Past Decade: A Nationwide Analysis. Diabetes Care 2018;41:1631–1638]]> https://www.researchpad.co/article/N82f80f54-9348-425d-9f87-d7c099157189 ]]> <![CDATA[Response to Comment on Bergenstal et al. Glucose Management Indicator (GMI): A New Term for Estimating A1C From Continuous Glucose Monitoring. Diabetes Care 2018;41:2275–2280]]> https://www.researchpad.co/article/N5fc29e9b-9c2d-4409-8f5b-a8947e9cddc4 ]]> <![CDATA[Response to Comment on Mathew et al. Therapeutic Lifestyle Changes Improve HDL Function by Inhibiting Myeloperoxidase-Mediated Oxidation in Patients With Metabolic Syndrome. Diabetes Care 2018;41:2431–2437]]> https://www.researchpad.co/article/Nee934cfd-95df-4400-9481-82343c68611a ]]> <![CDATA[Response to Comment on Doyle et al. Closed-Loop Artificial Pancreas Systems: Engineering the Algorithms. Diabetes Care 2014;37:1191–1197]]> https://www.researchpad.co/article/N40408103-6cfc-48ee-9728-7565dd3b6f03 ]]> <![CDATA[Metformin, arterial contrast and acute kidney injury]]> https://www.researchpad.co/article/N2a6bd9f7-297d-4a85-b31a-21a8804bac59 ]]> <![CDATA[Response to Comment on Jaiswal et al. Prevalence of and Risk Factors for Diabetic Peripheral Neuropathy in Youth With Type 1 and Type 2 Diabetes: SEARCH for Diabetes in Youth Study. Diabetes Care 2017;40:1226–1232]]> https://www.researchpad.co/article/5c8eeb1ed5eed0c484ef8ffb ]]> <![CDATA[Response to Comment on Young-Hyman et al. Psychosocial Care for People With Diabetes: A Position Statement of the American Diabetes Association. Diabetes Care 2016;39:2126–2140]]> https://www.researchpad.co/article/5c8eecf9d5eed0c484efbf92 ]]> <![CDATA[Response to comment on Lent et al. All-Cause and Specific-Cause Mortality Risk After Roux-en-Y Gastric Bypass in Patients With and Without Diabetes. Diabetes Care 2017;40:1379–1385]]> https://www.researchpad.co/article/5c6367fad5eed0c484b1af44 ]]> <![CDATA[Response to Comment on Lachin et al. Association of Glycemic Variability in Type 1 Diabetes With Progression of Microvascular Outcomes in the Diabetes Control and Complications Trial. Diabetes Care 2017;40:777–783]]> https://www.researchpad.co/article/5c11bec4d5eed0c48477e29e ]]> <![CDATA[Response to Comment on Lewis et al. Management of Hemoglobin Variants Detected Incidentally in HbA 1c Testing: A Common Problem Currently Lacking a Standard Approach. Diabetes Care 2017;40:e8–e9]]> https://www.researchpad.co/article/5c0e0cddd5eed0c484dcfc59 ]]> <![CDATA[Response to Comments on Young-Hyman et al. Psychosocial Care for People With Diabetes: A Position Statement of the American Diabetes Association. Diabetes Care 2016;39:2126–2140]]> https://www.researchpad.co/article/5c0d81e7d5eed0c484c06bbe ]]> <![CDATA[Response to Comment on Niewczas et al. Circulating Modified Metabolites and a Risk of ESRD in Patients With Type 1 Diabetes and Chronic Kidney Disease. Diabetes Care 2017;40:383–390]]> https://www.researchpad.co/article/5c092850d5eed0c4841e7ec2 ]]> <![CDATA[Response to Comment on Sarkar et al. Exenatide Treatment for 6 Months Improves Insulin Sensitivity in Adults With Type 1 Diabetes. Diabetes Care 2014;37:666–670]]> https://www.researchpad.co/article/5bc262c240307c2017bbd1b6 ]]> <![CDATA[Response to Comment on Hempe et al. The Hemoglobin Glycation Index Identifies Subpopulations With Harms or Benefits From Intensive Treatment in the ACCORD Trial. Diabetes Care 2015;38:1067–1074]]> https://www.researchpad.co/article/5b03a286463d7e698f0f557b ]]> <![CDATA[Response to Comment on Smith et al. Protein Ingestion Induces Muscle Insulin Resistance Independent of Leucine-Mediated mTOR Activation. Diabetes 2015;64:1555–1563]]> https://www.researchpad.co/article/5afdf258463d7e0eeca07e49 ]]> <![CDATA[Comment on Sato et al. Improving Type 2 Diabetes Through a Distinct Adrenergic Signaling Pathway Involving mTORC2 That Mediates Glucose Uptake in Skeletal Muscle. Diabetes 2014;63:4115–4129]]> https://www.researchpad.co/article/5bc4a17440307c3d1c481f43 ]]>